Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2022

View Archived Issues

HCAR2 targeting modulates the progression of AD in mice

IRF3 orchestrates obesity-induced inflammation and dysglycemia

Inhaled bispecific single-domain antibody neutralizes multiple SARS-CoV-2 variants

Allosteric regulators targeting GCase decrease toxic substrate accumulation in models of GD

Novel carbazole derivatives attenuate mitochondrial function in models of lung adenocarcinoma

Chengdu Origiant Pharmaceutical patents RIPK1 inhibitors

Guangzhou Maxinovel Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Betta Pharmaceuticals presents new CD73 inhibitors

J2H Biotech identifies new PROTACs for NSCLC

Compass Pathfinder synthesizes new safrylamine derivatives

LUM-015 shows potential for imaging of inflammatory protease activity in atherosclerosis

Tollovir and Tollovid show 3CL protease inhibition in vitro against Omicron SARS-CoV-2 variants

Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement

CARB-X option funding supports Clarametyx's development of anti-biofilm therapy CMTX-101

Plasma desmosine is a prognostic factor in acute myocardial infarction

TEM1 is a marker of heart failure severity

Gut reaction to rapamycin extends female fly lifespan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...